login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AURA BIOSCIENCES INC (AURA) Stock News
USA
-
Nasdaq
- NASDAQ:AURA -
US05153U1079
-
Common Stock
6.43
USD
-0.02 (-0.31%)
Last: 12/5/2025, 8:03:55 PM
6.43
USD
0 (0%)
After Hours:
12/5/2025, 8:03:55 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AURA Latest News, Press Relases and Analysis
All
Press Releases
13 days ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference
24 days ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights
3 months ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
4 months ago - By: The Motley Fool
Aura Biosciences Posts Q2 Cash Surge
4 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights
a year ago - By: Benzinga
Aura Biosciences Touts Promising Data From Eye Cancer Candidate
4 months ago - By: The Motley Fool
- Mentions:
AMZN
META
NVDA
AUR
...
4 Artificial Intelligence Stocks (That Aren't Nvidia) You Can Buy and Hold for the Next Decade
7 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
7 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants
7 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
7 months ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in Upcoming Investor Conferences
8 months ago - By: Benzinga
- Mentions:
STBX
LRHC
ASML
BLMZ
...
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
a year ago - By: BusinessInsider
AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024
a year ago - By: InvestorPlace
AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024
8 months ago - By: Yahoo Finance
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
8 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
9 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
9 months ago - By: Aura Biosciences, Inc.
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
9 months ago - By: Aura Biosciences, Inc.
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
9 months ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in Upcoming Investor Conferences
a year ago - By: Aura Biosciences, Inc.
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial
a year ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma
a year ago - By: Aura Biosciences, Inc.
Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024
a year ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in Upcoming Investor Conferences
a year ago - By: Aura Biosciences, Inc.
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
a year ago - By: Aura Biosciences, Inc.
Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights
2 years ago - By: Aura Biosciences, Inc.
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
2 years ago - By: Aura Biosciences, Inc.
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
Please enable JavaScript to continue using this application.